Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 5, 2012, Pages 1139-1147

  De Campos, Rafael O P ^a   Semelka, Richard C ^a   Azevedo, Rafael M ^a   Ramalho, Miguel ^a   Heredia, Vasco ^a   Armao, Diane M ^a   Woosley, John T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

combined hepatocellular cholangiocarcinoma; magnetic resonance findings; mixed; MR appearance; primary liver tumor

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHADENOPATHY; MALE; MIXED TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84867754684     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23754     Document Type: Article

References (36)

1. Allen RA, Lisa JR,. Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-655.
2. Yeh MM,. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol 2010; 25: 1485-1492.
3. Kassahun WT, Hauss J,. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 2008; 62: 1271-1278.
4. Kim JH, Yoon HK, Ko GY, et al. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 2010; 255: 270-277.
5. Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993; 18: 1090-1095.
6. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33: 283-287.
7. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-125.
8. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 2006; 36: 892-897.
9. Zuo H, Yan L, Zeng Y, et al. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6: 161-165.
10. Portolani N, Baiocchi GL, Coniglio A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008; 15: 1880-1890.
11. Panjala C, Senecal DL, Bridges MD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 2010; 10: 1263-1267.
12. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94: 2040-2046.
13. Wang J, Wang F, Kessinger A,. Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010; 2010 pii: 917356. Epub 2010 Sep 2.
14. Bhagat V, Javle M, Yu J, et al. Combined hepatocholangiocarcinoma: case-series and review of literature. Int J Gastrointest Cancer 2006; 37: 27-34.
15. Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 2009; 16: 623-629.
16. Nishie A, Yoshimitsu K, Asayama Y, et al. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings. AJR Am J Roentgenol 2005; 184: 1157-1162.
17. Sapisochin G, Fidelman N, Roberts JP, Yao FY,. Mixed hepatocellular- cholangiocarcinoma (HCC-CC) and intra-hepatic cholangiocarcinoma (I-CC) in patients transplanted for hepatocellular carcinoma. Liver Transpl 2011; 17: 934-942.
18. Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M,. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr 1997; 21: 52-58.
19. Choi BI, Han JK, Kim YI, et al. Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging 1994; 19: 43-46.
20. Ebied O, Federle MP, Blachar A, et al. Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients. J Comput Assist Tomogr 2003; 27: 117-124.
21. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y,. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma. Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res 2005; 32: 185-195.
22. Toh CH, Cheung YC, Ng SH, Lin CY, Chan SC, Ng KK,. Combined hepatocellular-cholangiocarcinoma: a case report. Int J Clin Pract 2004; 58: 1170-1173.
23. Shin C, Lee J, Kim S, et al. Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography. J Comput Assist Tomogr 2007; 31: 109.
24. Lin G, Toh CH, Wu RC, et al. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract 2008; 62: 1199-1205.
25. Phongkitkarun S, Srisuwan T, Sornmayura P, Jatchavala J,. Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT. J Med Assoc Thai 2007; 90: 113-120.
26. Hashimoto T, Nakamura H, Hori S, et al. MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging 1994; 19: 430-432.
27. Murakami T, Kim T, Tomoda K, et al. Combined hepatocellular and cholangiocellular carcinoma. Radiat Med 1997; 15: 243-246.
28. Schiettecatte A, Dujardin M, Beeck BOd, de Mey J,. Combined hepatocellular-cholangiocarcinoma: MR findings. Eur J Radiol Extra 2008; 67: e75-e77.
29. Jeon T, Kim S, Lee W, Lim H,. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdominal Imaging 2010; 35: 337-345.
30. Willekens I, Hoorens A, Geers C, Op de Beeck B, Vandenbroucke F, de Mey J,. Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia. World J Gastroenterol 2009; 15: 3940-3943.
31. Danet IM, Semelka RC, Leonardou P, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003; 181: 809-817.
32. Willatt JM, Hussain HK, Adusumilli S, Marrero JA,. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311-330.
33. Semelka RC, Martin DR, Balci C, Lance T,. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001; 13: 397-401.
34. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791-798.
35. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994; 193: 49-57.
36. Kierans AS, Leonardou P, Hayashi P, et al. MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 2010; 28: 790-796.